CERITINIB | CERITINIB | ATC L01XE28
ANTINEOPLASTIC ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITOR TREATMENT OF ANAPLASTIC LYMPHOMA KINASE (ALK)-POSITIVE METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) | ORAL | Tmax 5 HOUR VD 4230 LITER PPB 97 PERCENT Cl 33.2 LITER / HOUR HT 41 HOUR | ALK TYROSINE KINASE PDB 4MKC (CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE COMPLEXED WITH LDK378) LIGAND CODE = 4MK (link to the list of PDB complexes) Download experimental 3D coordinates of 4MK with added hydrogens | ALK TYROSINE KINASE RECEPTOR INHIBITOR CHEMBL4247 ALK TYROSINE KINASE RECEPTOR Q9UM73 ALK TYROSINE KINASE RECEPTOR HOMO SAPIENS ENZYME KINASE PROTEIN KINASE TKL STKR TYPE1 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |